Effectiveness of intraarterial administration of fasudil hydrochloride for preventing symptomatic vasospasm after subarachnoid hemorrhage

Acta Neurochirurgica, Supplementum

Volumn 120, Issue , 2015, Pages 297-301

  Saito, Atsushi ^a   Inoue, Mizuho ^a   Kon, Hiroyuki ^a   Imaruoka, Shunji ^a   Basaki, Kiyoshi ^a   Midorikawa, Hiroshi ^a   Sasaki, Tatsuya ^a   Nishijima, Michiharu ^a  

^a AOMORI PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Circulation time; Fasudil hydrochloride; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

CONTRAST MEDIUM; FASUDIL; 1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; VASODILATOR AGENT;

ADULT; ANEURYSM RUPTURE; ANGIOGRAPHY DEVICE; ANTERIOR COMMUNICATING ARTERY; ARTERIAL CIRCULATION; ARTERY BLOOD FLOW; ARTICLE; BRAIN CIRCULATION; BRAIN VASOSPASM; CIRCULATION TIME; CLINICAL ARTICLE; COIL EMBOLIZATION; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG EFFICACY; DRUG INDICATION; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; ARTIFICIAL EMBOLISM; BRAIN ANGIOGRAPHY; COMPLICATION; DRUG EFFECTS; INTRAARTERIAL DRUG ADMINISTRATION; RADIOGRAPHY; SURGICAL EQUIPMENT; VASOSPASM, INTRACRANIAL;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANGIOGRAPHY, DIGITAL SUBTRACTION; BLOOD CIRCULATION TIME; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR CIRCULATION; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; INJECTIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; SUBARACHNOID HEMORRHAGE; SURGICAL INSTRUMENTS; TREATMENT OUTCOME; VASODILATOR AGENTS; VASOSPASM, INTRACRANIAL;

EID: 84921776201     PISSN: 00651419     EISSN: 21978395     Source Type: Book Series    
DOI: 10.1007/978-3-319-04981-6_50     Document Type: Article

References (19)

1. Ingall T, Asplund K, Mahonen M, Bonita R (2000) A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study. Stroke 31:1054–1061
2. Inoue M, Sasaki T, Takazawa H, Morita T, Narisawa A, Saito A, Midorikawa H, Nishijima M (2013) Symptomatic vasospasm in elderly patients with aneurysmal subarachnoid hemorrhage: comparison with nonelderly patients. Acta Neurochir Suppl 115:281–284
3. Iseda T, Nakano S, Yoneyama T, Ikeda T, Moriyama T, Sameshima T, Goya T, Wakisaka S (2000) Angiographic cerebral circulation time before and after endovascular therapy for symptomatic vasospasm. Clin Radiol 55:679–683
4. Ito H, Inugami A, Shishido F, Okudera T, Ogawa T, Hatazawa J, Fujita H, Shimosegawa E, Kanno I, Fukuda H (1994) Circulation time determined by carotid angiography in patients with chronic internal carotid artery occlusion: Comparison with cerebral blood flow and oxygen metabolism measured by PET [in Japanese]. Kaku Igaku 31:1193–1199
5. Kim I, Leinweber BD, Morgalla M, Butler WE, Seto M, Sasaki Y, Peterson JW, Morgan KG (2000) Thin and thick fi lament regulation of contractility in experimental cerebral vasospasm. Neurosurgery 46:440–446
6. Ohkuma H, Manabe H, Tanaka M, Suzuki S (2000) Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 31:1621–1627
7. Okawara SH, Kimura J, Hahn JY (1974) Cerebral circulation time with ruptured intracranial aneurysms. J Neurosurg 41:415–420
8. Pradilla G, Thai QA, Legnani FG, Hsu W, Kretzer RM, Wang PP, Tamargo RJ (2004) Delayed intracranial delivery of a nitric oxide donor from a controlled-release polymer prevents experimental cerebral vasospasm in rabbits. Neurosurgery 55:1393–1400
9. Sasaki T, Kodama N, Kawakami M, Sato M, Asari J, Sakurai Y, Watanabe K, Onuma T, Matsuda T (2000) Urokinase cisternal irrigation therapy for prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: a study of urokinase concentration and the fi brinolytic system. Stroke 31: 1256–1262
10. Sato M, Tani E, Fujikawa H, Kaibuchi K (2000) Involvement of Rhokinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ Res 87:195–200
11. Satoh S, Yamaguchi T, Hitomi A, Sato N, Shiraiwa K, Ikegaki I, Asano T, Shimokawa H (2002) Fasudil attenuates interstitial fi brosis in rat kidneys with unilateral ureteral obstruction. Eur J Pharmacol 455:169–174
12. Satoh S, Hitomi A, Ikegaki I, Kawasaki K, Nakazono O, Iwasaki M, Mohri M, Asano T (2010) Amelioration of endothelial damage/ dysfunction is a possible mechanism for the neuroprotective effects of Rho-kinase inhibitors against ischemic brain damage. Brain Res Bull 81:191–195
13. Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K, Nagata I, Kikuchi H, Takemae T, Hidaka H (1992) Effect of AT877 on cerebral vasospasm after aneurismal subarachnoid hemorrhage. J Neurosurg 76:571–577
14. Shibuya M, Hirai S, Seto M, Satoh S, Ohtomo E (2005) Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial. J Neurol Sci 238:31–39
15. Siasios I, Kapsalaki EZ, Fountas KN (2013) Cerebral vasospasm pharmacological treatment: an update. Neurol Res Int. doi:10.1155/2013/571328
16. Suzuki Y, Shibuya M, Satoh S, Sugimoto Y, Takakura K (2007) A postmarketing surveillance study of fasudil treatment after aneurismal subarachnoid hemorrhage. Surg Neurol 68:126–132
17. Suzuki Y, Shibuya M, Satoh S, Sugiyama H, Seto M, Takakura K (2008) Safety and efficacy of fasudil monotherapy and fasudil-ozagrel combination therapy in patients with subarachnoid hemorrhage: sub-analysis of the post-marketing surveillance study. Neurol Med Chir 48:241–248
18. Udoetuk JD, Stiefel MF, Hurst RW, Weigele JB, LeRoux P (2007) Admission angiographic cerebral circulation time may predict subsequent angiographic vasospasm after aneurismal subarachnoid hemorrhage. Neurosurgery 61:1152–1161
19. Yamamoto S, Watanabe M, Uematsu T, Takasawa K, Nukata M, Kinoshita N (2004) Correlation of angiographic circulation time and cerebrovascular reserve by acetazolamide-challenged single photon emission CT. AJNR Am J Neuroradiol 25:242–247